CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense. by Carevic, M et al.
E-Mail karger@karger.com
 Research Article 
 J Innate Immun 2016;8:362–373 
 DOI: 10.1159/000444125 
 CXCR1 Regulates Pulmonary 
Anti- Pseudomonas Host Defense 
 M. Carevic a    H. Öz a    K. Fuchs f    J. Laval a    C. Schroth a    N. Frey a    
A. Hector a    T. Bilich a    M. Haug b    A. Schmidt b    S.E. Autenrieth c    K. Bucher d, e    
S. Beer-Hammer d, e    A. Gaggar h    M. Kneilling f    C. Benarafa j    J.L. Gao i    
P.M. Murphy i    S. Schwarz b    B. Moepps g    D. Hartl a  
 a  Children’s Hospital and Interdisciplinary Center for Infectious Diseases, Departments of  b  Medical Microbiology, 
 c  Internal Medicine II and  d  Pharmacology and Experimental Therapy, and e Interfaculty Center of Pharmacogenomics 
and Drug Research, University of Tübingen,  f  Werner Siemens Imaging Center, Department of Preclinical Imaging 
and Radiopharmacy, Eberhard Karls University Tübingen,  Tübingen , and  g  Institute of Pharmacology and 
Toxicology, Ulm University Medical Center,  Ulm , Germany;  h  Department of Medicine and Division of Pulmonary, 
Allergy, and Critical Care Medicine, University of Alabama at Birmingham,  Birmingham, Ala. , and  i  Molecular 
Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergic and Infectious Diseases, NIH, 
 Bethesda, Md. , USA;  j  Theodor Kocher Institute, University of Bern,  Bern , Switzerland 
through modulation of reactive oxygen species and inter-
ference with Toll-like receptor 5 expression. These studies 
define CXCR1 as a novel, noncanonical chemokine receptor 
that regulates pulmonary anti- Pseudomonas host defense 
with broad implications for CF, COPD and other infectious 
lung diseases.  © 2016 S. Karger AG, Basel 
 Introduction 
 Chemokines recruit immune cells to inflammatory 
sites through binding to cognate G-protein-coupled che-
mokine receptors  [1, 2] . Chemokine receptor-mediated 
leukocyte migration is of particular relevance for infec-
tious diseases to provide a cellular shield against invading 
pathogens. Neutrophils are the key effector cells of the 
innate immune system to combat bacterial and fungal in-
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 Abstract 
 Pseudomonas aeruginosa is a key opportunistic pathogen 
causing disease in cystic fibrosis (CF) and other lung diseas-
es such as chronic obstructive pulmonary disease (COPD). 
However, the pulmonary host defense mechanisms regulat-
ing anti- P. aeruginosa immunity remain incompletely un-
derstood. Here we demonstrate, by studying an airway  P. 
aeruginosa infection model, in vivo bioluminescence imag-
ing, neutrophil effector responses and human airway sam-
ples, that the chemokine receptor CXCR1 regulates pulmo-
nary host defense against  P. aeruginosa . Mechanistically, 
CXCR1 regulates anti- Pseudomonas neutrophil responses 
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fections, equipped with a variety of antimicrobial weap-
ons  [3–5] . Their physiological importance is exemplified 
in patients with neutropenia who suffer from life-threat-
ening invasive bacterial infections.
 While CC chemokines mainly act on mononuclear 
cells, neutrophils are primarily recruited by CXC che-
mokines to diseased microenvironments, particularly 
those binding CXCR1 and/or CXCR2, which are both 
highly expressed on the surface of neutrophils. Cxcr2 
knock-out mice and small-molecule inhibitors have 
provided evidence that Cxcr2 mediates neutrophil mi-
gration to sites of inflammation and infection  [6] . In 
contrast, the role of Cxcr1 remains enigmatic, owing to 
the lack of specific chemical inhibitors and the availabil-
ity of  Cxcr1 –/– mice  [7] . Solving the crystal structure of 
CXCR1 has recently paved the way for the development 
of CXCR1-specific targeting compounds  [8] . Several in-
vestigations have suggested a distinct and nonredun-
dant role for CXCR1: the dual inhibition of CXCR1 and 
CXCR2 demonstrates substantial differences compared 
to selective inhibition of CXCR2 in different disease 
models, including cancer  [7, 9] , indicating a specific role 
for CXCR1. HIV has been found to bind to CXCR1  [10] 
and variants in the  CXCR1 gene have been reported to 
modulate HIV disease activity  [11] and cystic fibrosis 
(CF)  [12] , a fatal pulmonary disease characterized by 
neutrophilic airway inflammation and infections with 
the Gram-negative opportunistic pathogen Pseudomo-
nas aeruginosa  [13–17] . Besides its role in CF,  P. aerugi-
nosa colonizes airways from patients with chronic ob-
structive pulmonary disease (COPD) and causes severe 
nosocomial lung infections in immunocompromised 
individuals and ventilated patients in intensive care 
units. An efficient host defense against  P. aeruginosa 
correlates with functional neutrophil responses in hu-
mans  [18] and in mice  [19] , supporting the concept that 
neutrophils represent a major effector cell type in host-
 Pseudomonas interactions. We demonstrated previous-
ly that loss of human CXCR1 on neutrophils in airway 
fluids from CF patients was associated with an impaired 
anti- Pseudomonas host defense ex vivo  [20] , suggesting 
indirectly that CXCR1 regulates host defense against  P. 
aeruginosa .
 Inspired by these previous findings, we sought to de-
cipher the function of Cxcr1 in vivo in the context of pul-
monary  P. aeruginosa  infection in a comprehensive man-
ner using newly generated  Cxcr1 knock-out mice. Here 
we demonstrate that Cxcr1 acts as a noncanonical che-
mokine receptor by regulating neutrophil- Pseudomonas 
interactions.
 Materials and Methods 
 Mouse Models 
 Cxcr1 –/– mice were generated by P. Murphy/NIH. Briefly, the 
 Cxcr1 gene was cloned from C57Bl/6 mouse genomic DNA. The 
targeting construct was created by replacement of the  Cxcr1 gene 
with the neomycin resistance gene, homologous recombinants of 
the targeted deletion were generated in mouse embryonic stem cell 
line R1 and chimeric mice were produced by microinjection of re-
combinant embryonic stem cells into C57Bl/6 blastocysts. The 
 Cxcr1 –/– mice used in the experiments have been backcrossed to 
C57Bl/6 mice for 11 generations. All animal studies were reviewed 
and approved by the Regierungspräsidium, Tübingen, Germany, 
and the Animal  Care and Use Committee (ACUC) at NIAID, NIH, 
USA, and were carried out according to the guidelines of the Ger-
man Law for the Protection of Animal Life. Mice were bred at the 
animal facility of the Institute of Pharmacology (Tübingen). Age- 
and sex-matched litter-mate controls were used for all experi-
ments.
 Isolation of Bone Marrow Cells 
 Negative selection of neutrophils from whole bone marrow 
cells was performed by Magnetic Cell Separation (MACS; Miltenyi 
Biotec) according to a previously published protocol, which allows 
isolation of highly purified primary untouched mouse neutrophils 
 [21] . Briefly, bone marrow cells were flushed from the femur of 
mice and stained with the following anti-mouse antibodies (all bi-
otinylated): CD5 (BD Biosciences), CD45R/B220 (BioLegend), 
CD49b/DX5, CD117, F4/80 (all eBioscience) and Ter 119 (BioLe-
gend). After incubation, the unbound antibodies were washed 
away. Bone marrow cells were then incubated with magnetic beads 
(MACS, Miltenyi Biotec) labeled with streptavidin. Bead-coupled 
bone marrow cells were removed by immunomagnetic separation 
following the manufacturer’s recommendation, resulting in highly 
purified neutrophils.
 Acute P. aeruginosa Infection 
 The mouse model of acute pulmonary  P. aeruginosa infection 
was performed as published recently by our group  [22] . Mice were 
infected intranasally with the  P. aeruginosa bacterial strain (PAO1) 
with doses ranging from 2 × 10 5 to 2 × 10 6 CFU, using established 
procedures  [22] . Infections were carried out under antagonizable 
anesthesia. An inoculum of PAO1 was administered intranasally 
(50 μl/nostril). After infection, mortality and body weight were 
monitored once a day over 1 week. In vivo bioluminescence imag-
ing was performed using a luciferase-expressing P. aeruginosa 
strain as published previously  [23] and infecting mice with and 5 × 
10 7 CFU intratracheally. Bioluminescence imaging was performed 
24 h after infection using an IVIS spectrum preclinical in vivo imag-
ing read-out system (Perkin Elmer, Rodgau-Jügesheim, Germany).
 Flow Cytometry 
 The panel of antibodies used to stain mouse bronchoalveolar la-
vage fluid (BALF), blood or bone marrow cells included F4/80 Pa-
cific-blue (clone BM8), CD19-PerCP/Cy5.5 (clone 6D5) and CD3 
brilliant violet (clone 17A2) from BioLegend, Siglec-F-PE (clone 
E50-2440), CD11b-PE-Cy7 (clone M1/70) and CD11c-APC-Cy7 
(clone HL3) from BD Biosciences and Ly6G/C-APC (clone RB6-
8C5) from eBioscience. Flow cytometry was performed using BD 
FACS Canto II flow cytometers (BD Biosciences), and data were 
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analyzed with FlowJo software. A panel of autofluorescence, CD11b, 
CD11c, CD15, CD16 and MHC-II (all BD Biosciences) was used to 
analyze human neutrophils and dendritic cells. Anti-mouse Toll-
like receptor 5 (TLR5)-Alexa Fluor 647 was from BioLegend (clone 
ACT5) and anti-human TLR5-FITC was from Imgenex/Novus 
(clone 19D759.2). Anti-mouse TLR4-PE (clone UT41) and anti-hu-
man TLR4-PE were from eBioscience (clone HTA125). Anti-hu-
man CXCR1-PE was from BD Biosciences (clone 5A12).
 Reactive Oxygen Species Production 
 For the determination of reactive oxygen species (ROS) pro-
duction, luminol-dependent chemiluminescence was used, which 
is an established method to measure intracellular ROS production 
 [24] . For this purpose, Cxcr1 +/+ and  Cxcr1 –/– neutrophils were iso-
lated from whole bone marrow as described above. The cells were 
used at a concentration of 2.5 × 10 5 /100 μl in Hank’s balanced salt 
solution (HBSS) with Ca2 + /Mg2 + and immediately stimulated 
with recombinant chemokines (100 ng), flagellin (100 ng), PMA 
(200 n M ) or PAO1 (2 × 10 6 /ml) diluted in HBSS buffer containing 
0.5 m M luminol (Sigma) and 120 μg/ml HRP. Chemiluminescence 
was measured at 37  °  C with a luminometer (Fluoroskan Ascent FL, 
ThermoScientific, Ascent software v2.6) for 19 min.
 Neutrophil Transmigration 
 We compared the chemotactic migration of neutrophils isolat-
ed from the bone marrow of age-matched  Cxcr1 +/+ and  Cxcr1 –/– 
mice towards recombinant Cxcr1/2 chemokines and the putative 
CXCR1/2-ligand acetylated proline-glycine-proline using an es-
tablished in vitro transwell migration system with a 3-μm pore size, 
as described previously in detail  [25, 26] .
 Bacteria 
 P. aeruginosa wild-type strains (PAO1) were used as published 
previously by our group  [22] . Strains of the culture collection were 
streaked on agar plates and incubated at 37  °  C overnight. Colonies 
were then inoculated into tryptic soy broth overnight. The next day, 
a 1: 100 dilution in tryptic soy broth was performed and bacteria 
were cultured at 37  °  C for 4 h. The optical density was measured at 
600 nm. A GFP-expressing P. aeruginosa strain was used for micro-
scopical imaging studies. A luciferase-expressing P. aeruginosa 
strain was used for bioimaging studies as published previously  [23] .
 Neutrophil-Pseudomonas Interactions 
 Bone marrow-isolated  Cxcr1 +/+ and  Cxcr1 –/– neutrophils (5 × 
10 5 ) were coincubated with opsonized PAO1 at MOI 50 for 7 or 60 
min (RPMI 1640, 10% FCS) with shaking at 50 rpm. The contents 
of each well were centrifuged (500  g , 10 min) and then washed 
twice with HBSS (Gibco). To assess extracellular killing, superna-
tants were harvested and plated in triplicate onto  Pseudomonas 
isolation agar plates. To assess intracellular killing, neutrophil pel-
lets were treated with gentamicin (400 μg/ml) to ensure that extra-
cellular and cell surface-associated bacteria were removed. Cells 
were washed twice in PBS, lysed with ice-cold water, and then plat-
ed in triplicate onto  Pseudomonas isolation agar plates. For micro-
scopical analyses, bacteria were stained using the LIVE/DEAD 
 BacLight TM bacterial viability kit according to the manufacturer’s 
instructions (Life Technologies, ThermoFisher) utilizing mixtures 
of SYTO 9 green-fluorescent nucleic acid stain and the red-fluo-
rescent nucleic acid stain, propidium iodide. SYTO 9 labels bacte-
ria with intact membranes and those with damaged membranes, 
while propidium iodide penetrates only bacteria with damaged 
membranes, causing a reduction in the SYTO 9 stain fluorescence 
when both dyes are present. After fixation (in 4% formaldehyde for 
10 min at room temperature), total bacteria (living and dead) were 
quantified using fluorescence microscopy. For image acquisition, 
a Leica DMRE microscope and an HCX PL APO ×100 (NA 1.35) 
oil objective was used.
 Asthma Mouse Models 
 Ovalbumin and house dust mite murine asthma models were 
performed as published previously by our group  [27] .
 Bronchoalveolar Lavage Fluid 
 BALF was obtained and processed as published previously by 
our group  [27] .
 Colony-Forming Units 
 Lungs were removed and homogenized in 1 ml PBS. Samples 
were serially diluted and plated on agar media for CFU counts 
overnight.
 Optical Imaging 
 We measured in vivo luciferase expression using the IVIS spec-
trum optical imaging system. Noninvasive in vivo optical imaging 
measurements were conducted 24 h after intratracheal infection of 
 Cxcr1 –/– and  Cxcr1 +/+ mice with luciferase-expressing  P. aerugi-
nosa bacteria (TBCF10839 isogenic mutant D8A6, 5 × 10 7 CFU/
mouse) as published previously  [23] . During measurements, mice 
were anesthetized by inhalation of isoflurane-O 2 (1.5% Forane, 
Abbott GmbH, Wiesbaden, Germany) and body temperature was 
maintained at 37  °  C. Regions of interest (ROIs) were drawn on the 
right and left lung of  Cxcr1 –/– and  Cxcr1 +/+ mice, which allows the 
semiquantitative analysis of the average radiance [p/s/cm2/sr] of 
the bioluminescence to be performed. Image analyses were per-
formed using Living Image software (Perkin Elmer).
 Experimental Peritonitis 
 Peritonitis was initiated by injection of 0.7 ml of sterile aged 4% 
thioglycollate broth intraperitoneally 4 h before harvest. The peri-
toneum was lavaged with 10 ml of PBS and cells were counted by 
flow cytometry as described above.
 Patients 
 BALF was analyzed from patients with non-CF chronic bron-
chitis (n = 5, mean age 22 years, with no P. aeruginosa infection) 
or from CF patients with chronic  P. aeruginosa  infections (n = 5, 
mean age 20 years) as described previously in detail  [20, 22] . 
CXCR1 and TLR5 surface expression levels (mean fluorescence 
intensity, MFI) were quantified on airway/BALF dendritic cells 
(CD11b + autofluorescence low CD11c high MHC-II high ) or neutro-
phils (CD11b + CD15 + CD16 + ) from patients with bronchitis or CF 
and  P. aeruginosa  infections. The study was approved by the Insti-
tutional Review Board/Ethical Committee of the University of 
Tübingen and meets the standards of the Declaration of Helsinki. 
Informed consent was obtained from all study subjects.
 Statistics 
 All calculations were performed using GraphPad Prism v6.0 
software. Statistical significance (p < 0.05) was determined using 
the Mann-Whitney U test or by ANOVA.
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 Fig. 1.  P. aeruginosa infections.  a Intracellular killing (upper panel) 
and extracellular killing (lower panel). Bone marrow-isolated neu-
trophils from age- and sex-matched  Cxcr1 +/+ and  Cxcr1 –/– mice 
were infected with PAO1 for 60 min at MOI 50, and CFU were 
counted. Data are from 5 independent experiments (means, 
SEMs).  b GFP-PAO1 bacteria and bone marrow-isolated neutro-
phils from age- and sex-matched  Cxcr1 +/+ and  Cxcr1 –/– mice were 
coincubated for 7 or 60 min at MOI 50. Bacteria were stained using 
a live/dead bacterial staining kit (left) and quantified microscopi-
cally (right). Representative images of  Cxcr1 +/+ (upper left) and 
 Cxcr1 –/– (lower left) neutrophils 60 min after GFP-PAO1 infection 
are shown. Living bacteria are shown in green and dead bacteria in 
red. Scale bar: 10 μm. Bars show percentages of living bacteria at 
7 min (upper right) and 60 min (lower right) at MOI 50. Data are 
from 5 independent experiments (means, SEMs).  c–e Age- and 
sex-matched  Cxcr1 +/+ and  Cxcr1 –/– mice were infected intranasal-
ly ( c ,  e ) or intratracheally ( d ) with PAO1 (except for  d , luciferase-
expressing TBCF10839 isogenic mutant D8A6). Lung CFU ( c ), 
bacterial lung in vivo clearance ( d ) and weight loss ( e ) were mon-
itored. For these experiments, 2 × 10 6 CFU ( c ), 5 × 10 7 ( d ) or 2 × 
10 5 to 2 × 10 6 CFU PAO1 ( e ) were inoculated.  c Bars represent 
medians; CFU were quantified in lungs 12 h after infection.  d Bio-
luminescence imaging was performed 24 h after the infection for 
5 ( Cxcr1 +/+ ) or 4 ( Cxcr1 –/– ) independent experiments; box and 
whiskers (range: min/max, quartiles, medians) are shown.  e Mean 
weight points for days 0–5 (d0–d5) are shown.  *  p < 0.05  Cxcr1 +/+ 
versus  Cxcr1 –/– mice. 
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 Results 
 Cxcr1 Regulates Anti-Pseudomonas Host Defense 
 Since we observed in previous studies that CXCR1 is 
involved in the antibacterial host defense functions of hu-
man neutrophils in vitro and associated with  P. aerugi-
nosa infections in patients with CF ex vivo  [12, 20] , we 
systematically investigated the role of Cxcr1 by employ-
ing  P. aeruginosa in vivo infection models. We started 
with quantifying the capacity of isolated  Cxcr1 –/– and 
 Cxcr1 +/+ neutrophils to kill  P. aeruginosa bacteria in vitro 
by using traditional CFU assays ( fig. 1 a) as well as by bac-
terial live/dead imaging methods ( fig. 1 b). These studies 
demonstrated that  Cxcr1 –/– neutrophils were impaired in 
intracellular, but not extracellular killing of  P. aeruginosa 
bacteria compared to their wild-type counterparts ( fig. 1 a, 
b). Next, we interrogated this bacterial clearance defect  in 
vivo and used a well-established  P. aeruginosa lung infec-
tion model. These studies confirmed our in vitro findings 
and demonstrated that  Cxcr1 –/– mice were impaired in 
clearing  P. aeruginosa from their lungs with an average of 
100-fold higher bacterial loads in the lungs of  Cxcr1 –/– 
mice compared to age- and gender-matched  Cxcr1 +/+ 
mice ( fig. 1 c). To visualize and quantify this impairment 
in bacterial clearance in a more refined spatiotemporal 
manner, we used a recently described in vivo biolumines-
cence imaging system ( fig. 1 d)  [23] . These studies con-
firmed that  Cxcr1 –/– mice were impaired in clearing  P. 
aeruginosa from their pulmonary compartment com-
pared to age- and gender-matched  Cxcr1 +/+ mice ( fig. 1 d). 
By inoculating different increasing doses of  P. aeruginosa 
into the airways, we found that this clearance defect led 
to a dose-dependent higher morbidity (as quantified by 
weight loss) in Cxcr1 –/– mice compared to age- and gen-
der-matched  Cxcr1 +/+ mice ( fig. 1 e), with significant dif-
ferences for the  P. aeruginosa CFU of 2 × 10 6 , but without 
significant differences at lower CFU.
 To exclude the possibility that the impaired pulmo-
nary host-defense in  Cxcr1 –/– mice is a mere reflection of 
an underlying basal defect in neutrophil homeostasis, we 
quantified total cells and neutrophils in bone marrow and 
peripheral blood and studied their apoptosis and necrosis 
ex vivo. These studies demonstrated that neither total cell 
counts nor total neutrophil counts in bone marrow (on-
line suppl. fig. S1A; for all online suppl. material, see 
www.karger.com/doi/10.1159/000444125) or peripheral 
blood (online suppl. fig. S1B) differed significantly be-
tween age-matched  Cxcr1 +/+ and  Cxcr1 –/– mice. Percent-
ages of neutrophils in bone marrow (online suppl. fig. 
S1A) were significantly increased in  Cxcr1 –/– compared 
to  Cxcr1 +/+  mice, but there was no significant difference 
in neutrophil percentages in peripheral blood between 
 Cxcr1 +/+ and  Cxcr1 –/– mice (online suppl. fig. S1B). Neu-
trophil survival studies demonstrated that neutrophil 
overall survival or neutrophil apoptosis did not differ be-
tween wild-type and knock-out animals, while there was 
a tendency towards less necrosis in  Cxcr1 –/– neutrophils 
compared to  Cxcr1 +/+ neutrophils (online suppl. fig. 
S1C).
 Cxcr1 Modulates ROS Production 
 Next, we sought to dissect the mechanisms by which 
Cxcr1 regulates pulmonary anti- P. aeruginosa host de-
fenses. Since the production of ROS is a key mechanism 
by which neutrophils kill bacteria, we compared ROS 
production between  Cxcr1 –/– and  Cxcr1 +/+ mice. These 
studies demonstrated that bone marrow cells isolated 
from  Cxcr1 –/– mice produced lower amounts of ROS 
upon stimulation with the recombinant chemokine 
CXCL8 compared to bone marrow cells from  Cxcr1 +/+ 
mice ( fig. 2 a). Since  P. aeruginosa  is a flagellated bacte-
rium and several previous studies have shown that flagel-
lin represents a key pathogen-associated molecular pat-
tern, which is essential for innate immune cell activation, 
we tested the effect of flagellin on ROS production by 
 Cxcr1 –/– and  Cxcr1 +/+ bone marrow myeloid cells. These 
studies demonstrated that, in line with CXCL8,  Cxcr1 –/– 
myeloid cells also showed impaired ROS production 
upon stimulation with bacterial flagellin compared to 
bone marrow myeloid cells from  Cxcr1 +/+ mice ( fig. 2 a). 
To further investigate whether these ROS changes in the 
myeloid compartment in  Cxcr1 +/+ mice were specifically 
due to neutrophils, we isolated bone marrow neutrophils. 
These studies consistently demonstrated that highly puri-
fied isolated  Cxcr1 –/– neutrophils, similar to nonfraction-
ated bone marrow cells, produced lower amounts of ROS 
compared to their  Cxcr1 +/+ counterparts upon stimula-
tion with the chemokine CXCL8 ( fig. 2 b), whole PAO1 or 
bacterial flagellin. We further extended these studies and 
included other Cxcr1/Cxcr2 chemokine receptor ligands 
into these assays. These studies demonstrated that 
 Cxcr1 –/– neutrophils showed a similar, albeit to a lesser 
extent than CXCL8, ROS impairment towards the puta-
tive Cxcr1 ligand Cxcl5 (LIX) as well as the recombinant 
chemokines Cxcl1 (KC) and Cxcl2 (MIP-2) ( fig.  2 b). 
Comparative analyses at the kinetic end point after neu-
trophil stimulation for all applied stimulants showed that 
ROS production by  Cxcr1 –/– neutrophils was significant-
ly impaired towards CXCL8, Cxcl1, Cxcl5, flagellin and 
 P. aeruginosa , but not Cxcl2 stimulation ( fig. 2 c, d). In 
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contrast to specific stimulation with chemokines,  P. aeru-
ginosa or bacterial flagellin, nonspecific stimulation with 
the phorbol ester PMA did not elicit a differential ROS 
production in unfractionated bone marrow myeloid cells 
( fig.  2 a) or isolated neutrophils from  Cxcr1 +/+ and 
 Cxcr1 –/– mice ( fig. 2 b–d), suggesting that Cxcr1-mediat-
ed ROS production is chemokine- and  P. aeruginosa- de-
pendent, rather than reflecting a redundant and universal 
basal ROS impairment. Collectively, these studies dem-
onstrate that Cxcr1 mediates anti- P. aeruginosa host de-
fense in neutrophils through a mechanism involving ROS 
production.
 Cxcr1 Modulates TLR5 Expression 
 Since generation of ROS is a universal antimicrobial 
host defense mechanism and not specifically related to  P. 
aeruginosa infections, we next investigated the role of 
TLR5 as a key pattern recognition receptor in  P. aerugi-
nosa -associated lung infections, such as CF  [28–32] . 
These studies demonstrated that genetic abrogation of 
 Cxcr1 led to an upregulation of Tlr5 surface expression 
on airway dendritic cells upon acute  P. aeruginosa infec-
tion ( fig. 3 a), whereas no changes were found on airway 
neutrophils ( fig. 3 a) or bone marrow dendritic cells or 
neutrophils ( fig. 3 b). To assess the human disease rele-
vance of these findings, we analyzed TLR5 expression on 
airway immune cells in patients with CF and  P. aerugi-
nosa infection, characterized by a loss of CXCR1  [20] . 
These investigations demonstrated that both dendritic 
cells and neutrophils ( fig. 3 c) in the airways of CF pa-
tients with  P. aeruginosa infection showed a loss of 
CXCR1 paralleled by a concomitant upregulation of 
TLR5 surface expression on the respective cell types 
compared to non-CF bronchitis patients without  P. ae-
ruginosa infection. No significant difference in TLR4 ex-
pression levels was noted between  Cxcr1 +/+ and  Cxcr1 –/–
 neutrophils (p > 0.05) or between CF patients with  P. 
aeruginosa infection and non-CF bronchitis patients 
without  P. aeruginosa infection (p > 0.05, data not 
shown). When viewed in combination, these studies in-
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dicate that a loss of CXCR1 in mice or human CF patients 
is associated with an upregulation of TLR5 expression on 
immune cells in the airways.
 Cxcr1 Is Dispensable for Neutrophil Migration 
 Since CXCR1 belongs to the family of chemokine re-
ceptors that primarily orchestrate leukocyte recruitment, 
we analyzed whether neutrophil migration is impaired 
in inflammatory settings in  Cxcr1 –/– mice in vivo  and by 
using isolated  Cxcr1 –/– neutrophils in vitro. To assess 
neutrophil migration in an in vivo setting, we compared 
neutrophil transmigration into the bronchoalveolar 
space upon  P. aeruginosa lung infection in  Cxcr1 +/+ and 
 Cxcr1 –/– mice. These studies demonstrated that neutro-
phils from  Cxcr1 –/– mice were equally potent in bron-
choalveolar infiltration compared to their wild-type 
counterparts ( fig.  4 a). To investigate whether this phe-
nomenon is restricted to the pulmonary compartment or 
is common at inflammatory sites in general, we compared 
 Cxcr1 +/+ and  Cxcr1 –/– neutrophil transmigration in a 
thioglycollate-induced peritonitis model. These studies 
demonstrated a tendency of  Cxcr1 –/– neutrophils towards 
a lower peritoneal infiltration compared to matched 
Cxcr1 +/+ neutrophils, which was, however, not statistical-
ly significant ( fig. 4 b). To further assess whether Cxcr1 
modulates noninfectious neutrophil transmigration dif-
ferentially, we compared  Cxcr1 +/+ and  Cxcr1 –/– neutro-
phil bronchoalveolar recruitment in 2 different models of 
allergic airway inflammation, namely ovalbumin-in-
duced ( fig. 4 c) and house dust mite-induced airway in-
flammation ( fig. 4 d). These studies consistently demon-
strated that  Cxcr1 –/– neutrophils showed no impairment 
in migrating into the bronchoalveolar compartment 
upon noninfectious allergic airway inflammation.
 To precisely investigate the migratory characteristics 
of  Cxcr1 +/+ and  Cxcr1 –/– neutrophils in vitro, we com-
pared the chemotactic migration of neutrophils isolated 
from bone marrow from age-matched  Cxcr1 +/+ and 
 Cxcr1 –/– mice towards Cxcr1/2 chemokines using a 
transwell migration system  [25, 26] . Consistent with our 
in vivo findings, these in vitro studies demonstrated that 
 Cxcr1 –/– neutrophils were not impaired in migrating to 
CXCR1/2 chemokines, but even rather showed a ten-
dency towards a more efficient chemotactic migration, 
particularly towards recombinant CXCL8, which has 
been previously described to activate Cxcr1  [33] ( fig. 4 e). 
Taken together, these studies demonstrate that Cxcr1 is 
dispensable for neutrophil migration in infectious and 
noninfectious conditions  in vitro  and  in vivo.
 Discussion 
 While traditionally chemokines and their receptors 
have been limited to their role in leukocyte recruitment, 
a growing body of evidence suggests that these G-protein-
coupled receptors have much broader roles in regulating 
physiological and pathophysiological processes at several 
levels  [1, 34, 35] . Here, we demonstrate that the chemo-
kine receptor Cxcr1 is dispensable for neutrophil trans-
migration under infectious and sterile inflammatory con-
ditions, but regulates ROS production and TLR5 surface 
expression as critical bacterial sensing (TLR5) and killing 
(ROS) mechanisms. This cellular effector mechanism has 
disease relevance, as genetic deficiency of  Cxcr1 increases 
the susceptibility towards  P. aeruginosa  infections, which 
are a significant mortality factor in patients with CF or 
individuals with immunosuppression or on ventilation.
 A variety of studies have analyzed the role of CXCR2 
in vivo, supporting the concept that CXCR2 mediates 
neutrophil migration to sites of inflammation  [6, 36] . In 
contrast, the role of Cxcr1 in vivo has not been defined so 
far due to a lack of a murine knock-out mouse model. 
Here, we provide evidence, inspired by our previous hu-
man data and mechanistic in vitro studies  [12, 20, 37] , 
that  Cxcr1 –/– mice show an impaired pulmonary neutro-
philic host defense against  P. aeruginosa , mediated 
through a ROS- and TLR5-mediated mechanism. More-
over, our studies demonstrate that neutrophil migration 
to the pulmonary site of inflammation and infection is 
not impaired in  Cxcr1 –/– mice. Therefore, in contrast to 
CXCR2, which is primarily involved in neutrophil re-
cruitment, Cxcr1, based on our data, is dispensable for 
neutrophil recruitment but mediates neutrophil effector 
functions by a mechanism involving ROS and TLR5. The 
underlying subcellular pathways remain to be elucidated, 
but our studies highlight the notion that chemokine re-
ceptors play a broader role in leukocyte biology than me-
diating cell migration by regulating antimicrobial effector 
and bacterial sensing mechanisms.
 Previous studies on human patients with CF who suf-
fer from chronic  P. aeruginosa infection showed that 
 CXCR1/2 polymorphisms modulate the disease outcome 
of these patients  [12] . Furthermore, previous studies at 
the cellular and ex vivo level provided indirect evidence 
that human IL-8R1 (CXCR1), but not IL-8R2 (CXCR2), 
is involved in NADPH oxidase and phospholipase D ac-
tivation  [38] and anti- P. aeruginosa host defense func-
tions  [20] . Our in vivo studies confirm and extend these 
findings by demonstrating that Cxcr1 plays a novel and 
noncanonical role in host-pathogen interactions by regu-
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lating neutrophil ROS effector response without affecting 
neutrophil recruitment, homeostasis or survival. Since 
ROS are essential for host defense against a variety of bac-
terial pathogens beyond  P. aeruginosa , these findings may 
have broad implications for infectious diseases. More-
over, ROS have been implicated in the proinflammatory 
harmful activities in chronic disease conditions, such as 
cardiovascular and chronic lung diseases  [39, 40] , sug-
gesting that interfering with CXCR1 pharmacologically 
may have the potential to dampen oxidative stress in 
chronic diseases in vivo.
 In contrast to CXCR2, which mediates neutrophil 
transmigration in vitro  and in vivo, our studies strongly 
support the notion that Cxcr1 does not mediate neutro-
phil migration. Conversely,  Cxcr1 –/– neutrophils showed 
even a higher migratory potential in transwell assays in 
vitro, mainly towards the 2 putative Cxcr1 ligands Cxcl5 
and CXCL8. While we have currently no explanation for 
this observation, we are tempted to speculate that, in line 
with previous findings in other CXC chemokine recep-
tors, Cxcr1 may serve as a negative regulator of Cxcl5- 
and/or CXCL8-triggered leukocyte migration by acting 
as decoy receptor. An alternative hypothesis is that of 
CXCR1/CXCR2 heterodimerization  [41] , suggesting 
that the loss of Cxcr1 could have an impact on Cxcr2 re-
ceptor surface expression on neutrophils. While we ob-
served no significant differences in Cxcr2 MFI surface 
expression levels between Cxcr1 +/+ and  Cxcr1 –/– neutro-
phils (online suppl. fig.  2A), we found moderately in-
creased percentages of Cxcr2 + neutrophils in the bone 
marrow of  Cxcr1 –/– compared to  Cxcr1 +/+  mice (online 
suppl. fig. 2B), suggesting that the observed tendency to-
wards a higher migratory capacity of  Cxcr1 –/– neutro-
phils in vitro could be due to a relative increase of Cxcr2 + 
neutrophils. Moreover, the loss of Cxcr1 receptors prob-
ably also increases the availability of Cxcr1/Cxcr2 ligands 
for Cxcr2 binding. However, in-depth biochemical and 
pharmacological analyses would be required to dissect 
this interaction, which was beyond the scope of this 
study.
 Beyond the involvement of ROS and Tlr5, the precise 
cellular mechanism(s) by which Cxcr1 is involved in anti-
 P. aeruginosa  neutrophil activities remains elusive. Our 
in vitro read-out system provided evidence for an im-
paired intracellular, but not extracellular, killing capacity 
of  Cxcr1 –/– neutrophils. Based on this finding and the fact 
that we did not observe signs of neutrophil extracellular 
trap formation in our short-term in vitro assay systems, 
we speculate that the Cxcr1-mediated antibacterial mech-
anism in our experimental system mainly involved ROS-
dependent intracellular phagocytic killing. Since our 
studies were, however, restricted to  P. aeruginosa , we can-
not exclude the possibility that Cxcr1 differentially regu-
lates antimicrobial effector mechanisms depending on 
the type of pathogen.
 We found that  Cxcr1 –/– neutrophils were impaired in 
generating ROS in response to  P. aeruginosa  or bacterial 
flagellin, whereas no difference was observed in response 
to nonbacterial generic ROS activation by stimulation 
with PMA. These findings inspired us to investigate the 
interaction of CXCR1 and flagellin-sensing pathways in 
mice and CF patients with  P. aeruginosa  infections. Our 
studies indicated that a loss of CXCR1 in mice or human 
CF patients leads to an upregulation of the flagellin recep-
tor TLR5 on the surface of immune cells in the infected 
airways. Based on these findings, we speculate that in 
neutrophil- P. aeruginosa  interactions, CXCR1 collabo-
rates with TLR5 to efficiently combat  P. aeruginosa . 
When CXCR1 is abrogated, this bacterial sensing (TLR5) 
and killing (ROS) mechanism is impaired, leading to un-
controlled P. aeruginosa  infections. Previous studies pro-
vided evidence for a TLR-chemokine receptor cross-talk 
in lipid rafts in monocytes and macrophages in response 
to the Gram-negative bacterium  Porphyromonas gingiva-
lis  [42] . The precise subcellular CXCR1/TLR5 interaction 
mechanisms in neutrophil- P. aeruginosa host defense re-
main to be dissected in future studies.
 A clear limitation of our study, regarding the human 
disease translation, is the  P. aeruginosa infection model 
that we used, which reflects acute pneumonia rather than 
chronic infective disease as is found in CF or COPD air-
ways. However, our primary aim was to define the role of 
Cxcr1 in anti- P. aeruginosa host defense as a proof-of-
principle in vivo using a well-established infection model, 
while chronic infection/colonization models were be-
yond our scope and have to be investigated in future stud-
ies. Some further aspects of our study remained poorly 
defined and should be investigated in the future. (1) What 
is the underlying reason for the difference in bone mar-
row neutrophils between  Cxcr1 –/– and  Cxcr1 +/+  mice? (2) 
Are differential chemokines released by Cxcr1 –/– and 
 Cxcr1 +/+ neutrophils that could directly (as shown previ-
ously in the human system for the chemokine CXCL6  [43, 
44] ) or indirectly (through auto/paracrine effects) affect 
bacterial killing? (3) What is the underlying mechanism 
behind the upregulation of Tlr5 on  Cxcr1 –/– dendritic 
cells? Are TLR5-ROS interactions involved?  [45] (4) 
What are the intracellular Cxcr1-downstream pathways 
regulating neutrophil effector responses?
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 In summary, our studies demonstrate that CXCR1 
regulates anti- P. aeruginosa host defense through a ROS- 
and TLR5-mediated mechanism. Beyond CF, these find-
ings may have broader implications for other  P. aerugi-
nosa -associated pulmonary disease conditions, such as 
COPD or ventilator-associated pneumonia. Moreover, 
our results point towards caution in targeting chemokine 
receptors  [46] without considering their so far underap-
preciated antimicrobial roles.
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